Clinical trial
SLR/NMA of Multaq® vs Sotalol to Assess for Safety in Patients With Atrial Fibrillation (AFib)
NCT05279833 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SLR/NMA of Multaq® vs Sotalol to Assess for Safety in Patients With Atrial Fibrillation (AFib)
- Lead sponsor
- Sanofi
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 24, 2021
- Completion date
- March 31, 2022
- Enrollment
- 87,810 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.